About 84,465 results

ALLMedicine™ Schizophrenia Center

Research & Reviews  27,506 results

Amisulpride steady-state plasma concentration and adverse reactions in patients with sc...
International Clinical Psychopharmacology; Qu K, Zhou Q et. al.

Jul 3rd, 2022 - The aim of the study was to evaluate the reference range of amisulpride for Chinese patients with schizophrenia and to assess its possible influencing factors based on therapeutic drug monitoring information. The relative adverse reactions of pati...

Assessing coherence through linguistic connectives: Analysis of speech in patients with...
Schizophrenia Research; Corona-Hernández H, de Boer JN et. al.

Jul 2nd, 2022 - Incoherent speech is a core diagnostic symptom of schizophrenia-spectrum disorders (SSD) that can be studied using semantic space models. Since linguistic connectives signal relations between words, they and their surrounding words might represent...

Exonic deletions in IMMP2L in schizophrenia with enhanced glycation stress subtype.
PloS One; Yoshikawa A, Kushima I et. al.

Jul 2nd, 2022 - We previously identified a subtype of schizophrenia (SCZ) characterized by increased plasma pentosidine, a marker of glycation and oxidative stress (PEN-SCZ). However, the genetic factors associated with PEN-SCZ have not been fully clarified. We p...

Effectiveness of personal recovery facilitators in adults with schizophrenia and other ...
Schizophrenia Research; Isaacs AN, Brooks H et. al.

Jul 2nd, 2022 - This review aimed to examine the evidence base for the use of personal recovery facilitators [non-psychopharmacological approaches] for adults with a diagnosis of schizophrenia and other psychoses. A systematic review (umbrella review) was conduct...

Symptom dimensions stability over time in recent onset psychosis: A prospective study.
Schizophrenia Research; Golay P, Ramain J et. al.

Jul 2nd, 2022 - The factorial structure of schizophrenia symptoms has been much debated but little is known on its degree of unicity, specificity as well as its dynamic over time. Symptom differentiation is a phenomenon according to which patients' symptoms could...

see more →

Guidelines  10 results

The American Psychiatric Association Practice Guideline for the Treatment of Patients W...
The American Journal of Psychiatry; Keepers GA, Fochtmann LJ et. al.

Sep 2nd, 2020 - The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia.|2020|Keepers GA,Fochtmann LJ,Anzia JM,Benjamin S,Lyness JM,|methods,methods,methods,classification,therapeutic use,diagnosis,therapy,

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated r...
Journal of Psychopharmacology (Oxford, England); Barnes TR, Drake R et. al.

Dec 13th, 2019 - These updated guidelines from the British Association for Psychopharmacology replace the original version published in 2011. They address the scope and targets of pharmacological treatment for schizophrenia. A consensus meeting was held in 2017, i...

EPA guidance on physical activity as a treatment for severe mental illness: a meta-revi...
European Psychiatry : the Journal of the Association of E... Stubbs B, Vancampfort D et. al.

Sep 28th, 2018 - Physical activity (PA) may be therapeutic for people with severe mental illness (SMI) who generally have low PA and experience numerous life style-related medical complications. We conducted a meta-review of PA interventions and their impact on he...

BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascu...
Journal of Psychopharmacology (Oxford, England); Cooper SJ, Reynolds GP et. al.

May 6th, 2016 - Excess deaths from cardiovascular disease are a major contributor to the significant reduction in life expectancy experienced by people with schizophrenia. Important risk factors in this are smoking, alcohol misuse, excessive weight gain and diabe...

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biologica...
The World Journal of Biological Psychiatry : the Official... Hasan A, Falkai P et. al.

Jul 28th, 2012 - These updated guidelines are based on a first edition of the World Federation of Societies of Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in 2005. For this 2012 revision, all available publications pertaini...

see more →

Drugs  954 results see all →

Clinicaltrials.gov  2,944 results

A Longitudinal Investigation of the Endocrine and Neurobiologic Events Accompanying Puberty

Jul 1st, 2022 - Despite the clear importance of adolescence in the emergence of a number of disease states and processes, there is surprisingly little known about how the endocrine and metabolic events accompanying puberty in humans impact normal developmental ne...

Neural Correlates of Sensory Phenomena in Tourette Syndrome

Jul 1st, 2022 - Tourette syndrome (TS) is a neurodevelopmental disorder affecting 1% of school-aged children; one-third of patients suffer persistent tics into adulthood. Diagnostic criteria rely solely on motor symptoms, but sensory phenomena are a nearly univer...

Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography

Jul 1st, 2022 - OBJECTIVES Dopaminergic (DA) modulation of brain function is disturbed in several disabling psychiatric disorders and represents the target of key psychopharmacologic agents, such as neuroleptics. Schizophrenia has been considered a prototype of d...

Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers

Jul 1st, 2022 - This protocol is meant to provide a matrix for multiple, simultaneous brain imaging investigations using magnetic resonance imaging (MRI) at 3.0 Tesla (3T). We intend to study regional brain structure, physiology, and biochemistry in living human ...

Inpatient Evaluation of Adults With Schizophrenia

Jul 1st, 2022 - Objectives: Schizophrenia and related psychoses are chronic brain disorders whose prognosis is often poor and whose pathophysiology remains obscure. Neuroimaging technologies such as PET (positron emission tomography), fMRI (functional magnetic re...

see more →

News  2,359 results

3 steps to bend the curve of schizophrenia
Henry A. Nasrallah, MD

Jul 1st, 2022 - Schizophrenia is arguably the most serious psychiatric brain syndrome. It disables teens and young adults and robs them of their potential and life dreams.

Adaptive changes to antipsychotics: How to avoid the consequences
Ahmad Sleem, MBBCh, Rif S. El-Mallakh, MD

Jul 1st, 2022 - While our understanding of the mechanisms of psychosis continues to evolve beyond the dopamine hypothesis, the key role of dopamine in psychosis and its treatment has not faded. 1 Over time, the dopamine hypothesis of schizophrenia has evolved from.

Best Strategy to Prevent Schizophrenia Relapse Yields Unexpected Results

Jun 29th, 2022 - A large meta-analysis sheds light on the best antipsychotic maintenance strategy to prevent relapse in clinically-stable schizophrenia — with some unexpected results that have potential implications for changes to current guidelines. Consistent wi...

Sleep a Potential Treatment Target for Schizophrenia?

Jun 27th, 2022 - A new analysis reveals a bidirectional relationship between sleep patterns and schizophrenia, leading researchers to suggest that sleep may be a potential treatment target for the disorder. Applying a Mendelian randomization (MR) approach, the inv...

Transdermal Med May Directly Target Hostility in Schizophrenia

Jun 22nd, 2022 - HP-3070, an asenapine transdermal system, is superior to placebo in reducing schizophrenia-associated hostility, results of a phase 3 study show. The results suggest that these effects are at least partially independent of general antipsychotic ef...

see more →

Patient Education  13 results see all →